TRUVADA is a prescription antiviral medicine containing emtricitabine 200 mg and tenofovir disoproxil 245 mg. It is used to treat HIV-1 infection (together with other HIV medicines) and to help prevent HIV infection (PrEP) in people at high risk of exposure.

Key Points

• Active ingredients: Emtricitabine 200 mg + Tenofovir disoproxil 245 mg.
• Pack size: 30 tablets.
• Used for HIV treatment in combination with other antiretroviral medications.
• Used for HIV prevention (PrEP) in adults and adolescents at risk of HIV infection.
• Works by blocking HIV replication, helping reduce the amount of virus in the body.
• Usually taken as one tablet once daily, as directed by a healthcare provider.
• Not a cure for HIV/AIDS, but helps control the infection and reduce transmission risk when used correctly.
• Requires regular medical follow-up, including HIV testing and kidney function monitoring.

Common Side Effects

• Nausea
• Diarrhea
• Headache
• Fatigue
• Dizziness
• Stomach discomfort

Important Warning

TRUVADA should only be used under medical supervision. Kidney function and HIV status should be monitored regularly during treatment or PrEP use.

One-Line Summary

TRUVADA 200 mg/245 mg is an antiviral medication used to treat HIV-1 infection and to help prevent HIV infection (PrEP) when taken as prescribed